Pfizer Inc and BioNTech SE said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 omicron variant, which…

Read more »

The post Pfizer and BioNTech Launch Trial of Omicron-Targeted COVID Vaccine appeared first on Hamodia.

In related news:

  1. CDC Says Testing Not Needed for Some Exposed to COVID-19, Sparking Outcry
  2. Moderna on Track to Report COVID-19 Vaccine Data Later This Month
  3. Many Americans Flying for Thanksgiving Despite CDC Pleas
  4. U.S. Health Officials: More Data Needed on U.K. COVID-19 Variant Warning
  5. Wisconsin Pharmacist Accused of Destroying Dozens of COVID Vaccine Doses to Plead Guilty